| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Richard C. Pasternak | |
| P2860 | cites work | Prediction of Coronary Heart Disease Using Risk Factor Categories | Q22241923 |
| Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 | ||
| Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction | Q29618673 | ||
| AHA/ACC scientific statement: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology | Q33751628 | ||
| The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals | Q41722263 | ||
| Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials | Q73304754 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Cardiology and cardiovascular medicine | Q96320350 |
| P304 | page(s) | 393-398 | |
| P577 | publication date | 2003-08-01 | |
| P1433 | published in | Cardiology clinics | Q2600141 |
| P1476 | title | Report of the Adult Treatment Panel III: the 2001 National Cholesterol Education Program guidelines on the detection, evaluation and treatment of elevated cholesterol in adults | |
| Report of the adult treatment panel III: the 2001 National Cholesterol Education Program guidelines on the detection, evaluation and treatment of elevated cholesterol in adults | |||
| P478 | volume | 21 |
| Q35901549 | A multidimensional integrative medicine intervention to improve cardiovascular risk |
| Q41228148 | Almonds ameliorate glycemic control in Chinese patients with better controlled type 2 diabetes: a randomized, crossover, controlled feeding trial |
| Q37777906 | Barriers to cardiovascular disease risk scoring and primary prevention in Europe |
| Q81281199 | Clinical assessment of the risk for sudden cardiac death in patients with sickle cell anemia |
| Q46697275 | Endothelial function in the forearm circulation of patients with the metabolic syndrome--effect of different lipid-lowering regimens |
| Q92671887 | Estimation of apolipoprotein A in early onset ST-segment elevation myocardial infarction |
| Q37113328 | Inflammatory markers and cardiovascular risks among overweight-obese Emirati women |
| Q34695239 | Influence of acute hyperlipidemia to adipocyte-derived hormones in lean normotensive and subjects with metabolic syndrome. |
| Q34655486 | Journey in guidelines for lipid management: From adult treatment panel (ATP)-I to ATP-III and what to expect in ATP-IV. |
| Q48065678 | Low-density lipoprotein cholesterol level and statin use among Medicare beneficiaries with diabetes mellitus |
| Q33267324 | Polymorphism in the MHC2TA gene is associated with features of the metabolic syndrome and cardiovascular mortality |
| Q35845802 | Prevalence and risk factors of premature coronary artery disease in patients undergoing coronary angiography in Kurdistan, Iraq |
| Q84949705 | Self-reported treatment adherence in inflammatory bowel disease in Indian patients |
| Q47295644 | Weight loss and improvement of lipid profiles in morbidly obese patients after laparoscopic one-anastomosis gastric bypass: 2-year follow-up |
| Q84871236 | [Treatment adherence in inflammatory bowel disease. Strategies for improvement] |
Search more.